Genius Sports is maintained at a buy rating with an $11.7 price target, implying 18% upside from current levels. GENI's Media technology segment is accelerating, growing 89% YoY in Q3, and is expected to become increasingly central to the business. Margin expansion is anticipated as ad-tech leverages existing data rights, creating higher incremental profitability.
Microsoft is positioned to capitalize on the massive AI buildout. Meta Platforms sold off despite a strong quarter.
Nvidia is a part owner of Nebius and Applied Digital. Both companies benefit from the huge construction projects in data centers.
Berkshire Hathaway's recent investment in Alphabet (GOOGL) signals a bold bet on the company's AI leadership and future free cash flow growth. SECURE Waste Infrastructure Corp. (SES:CA) offers a mini-Waste Management model, high recurring cash flow, aggressive buybacks, and trades at a discount to peers. Copart (CPRT) boasts a unique landowner business, wide moat, pristine balance sheet, and strong growth prospects driven by its digital salvage auction platform.
Genus PLC (LSE:GNS) shares trotted 8% to 2,567p after the livestock genetics company reported a "strong start" to its financial year, with adjusted profit before tax expected to be "modestly" ahead of the current City consensus forecast. Forecasts for the year to June 2026, the range of analyst forecasts for currency-adjusted profit before tax is from £77.6 million to £85 million, with the average at £80.5 million, the FTSE 250-listed group said in a short statement ahead of its annual shareholder meeting.
Genus PLC (LSE:GNS) shares leapt almost 11% higher on Thursday morning after the livestock genetics group sealed a new China deal and announced a 24% increase in annual profits. The FTSE 250-listed group reported adjusted profit before tax of £74.3 million, up 38% at constant currency rates, boosted by broad-based growth across its porcine genetics business (PIC) and profitability improvements in bovine (ABS).
Jeremy Szafron joins Kitco News as an anchor and producer from Kitco's Vancouver bureau. Jeremy is a seasoned journalist with a diverse background covering entertainment, current affairs and finance.
Shore Capital has nudged up its valuation for animal genetics group Genus PLC (LSE:GNS), raising the fair value from 2,750p to 2,900p and sticking with a buy recommendation ahead of full-year results next month. The upgrade reflects stronger-than-expected cash conversion, faster debt reduction and improving margins, particularly in the bovine (ABS) division.
Genus PLC's (LSE:GNS) shares rose 7% following a strong trading update for the year ending June 2025. The animal genetics group reported underlying performance in line with expectations and highlighted double-digit profit growth in its PIC pig breeding business.
Coinbase remains a strong buy due to resilient fundamentals, diversified revenue, and robust growth in subscriptions and services, even amid crypto market volatility. The GENIUS Act is a major catalyst, providing regulatory clarity for stablecoins, unlocking institutional and corporate adoption, and expanding Coinbase's total addressable market. Despite high valuation premiums, I believe Coinbase's rapid revenue growth and stablecoin-driven margin expansion justify the upside potential, with 81% share price appreciation possible.
MicroStrategy's new STRD preferred stock offers a 10% yield, targeting yield-seeking, risk-tolerant investors. STRD sits below STRF and STRK in seniority, increasing risk but also enhancing the creditworthiness and market appeal of senior preferreds. This capital stack innovation will allow MSTR to raise funds at lower costs, maximizing Bitcoin accumulation while minimizing dilution for common shareholders.
Genius Sports powers the global sports betting ecosystem with exclusive data partnerships and a vertically integrated, high-margin business model. Robust top-line growth, expanding margins, and a healthy balance sheet justify the current premium valuation, despite early-stage profitability. Key risks include client concentration, contract renewals, regulatory hurdles, and valuation sensitivity, but the long-term growth outlook remains compelling.